Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

In partnership with the Silicon Valley Business Journal, we'll honor the Bay Area's top companies recognized as the Best ...

Celebrating the top Seed stage investors in 2025 who made early bets on the startups driving today’s AI revolution.

Eli Lilly acquires SiteOne Therapeutics for up to $1B, signaling potential uptick in Big Pharma deals and focus on non-opioid ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...

How unfortunate if taxes restrain the global cooperation so essential to progress, including life-saving cures.

Health Secretary Robert F. Kennedy Jr. took aim at reputed journals such as the Lancet and said the agency will create ...

Orchestra BioMed holds two best-in-class medical device therapies targeting large markets. Find out why OBIO stock is a Buy.

In this Pharmaceutical Executive exclusive, Bob Jansen, David Shulkin, Gen. Paul Funk (Ret.), and Maj. Gen. Dennis LeMaster ...

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

Unless these journals change dramatically, we are going to stop NIH scientists from publishing there and we are going to create our own journals, in-house,” Kennedy Jr. said.

It's been a challenging year for NovoCure (NASDAQ: NVCR), an oncology-focused biotech. NovoCure's average price target on ...